The fight against pancreatic cancer has taken a step forward in Germany, with 120 hospitals now legally entitled to negotiate…
Tackling a Major Health Challenge Gastrointestinal (GI) diseases, including colorectal cancer, are a significant global health issue. In 2020 alone,…
Slightly below expectations December 2024 quarter CPI data released today were warmly received by stock market investors. The stats, which…
In a strategic move to bolster its governance and corporate strategy, OncoSil Medical Limited (ASX:OSL), a leader in pancreatic cancer…
RYONCIL® (remestemcel-L) becomes the first mesenchymal stromal cell (MSC) product approved by the US Food and Drug Administration (FDA) for…
Calls from some quarters for the RBA to slip an interest rate cut into borrowers’ Christmas stockings have gone unheeded,…